Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H Parving

Showing results (31-40 of 376) with videos related to

Pageof 38
Sort By:
Bibliotheca Anatomica|January 1, 1975
Microvascular permeability of albumin in untreated and treated essential hypertension, and during acute induced hypertensionH H Parving
Blood Pressure. Supplement|July 24, 2001
Hypertension and diabetes: the scope of the problemH H Parving
Lancet (London, England)|August 26, 1998
Hypertension Optimal Treatment (HOT) trialH H Parving
Diabetes Care|February 24, 2001
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetesH H Parving, P Rossing
The Journal of Diabetic Complications|April 1, 1988
High blood pressure is a major factor in progression of diabetic nephropathyH H Parving, E Hommel
BMJ (Clinical Research Ed.)|July 22, 1989
Prognosis in diabetic nephropathyH H Parving, E Hommel
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1973
Albumin transcapillary escape rate and plasma volume during long-term beta-adrenergic blockade in essential hypertensionH H Parving, F Gyntelberg
Current Opinion in Nephrology and Hypertension|May 1, 1994
The use of antihypertensive agents in prevention and treatment of diabetic nephropathyH H Parving, P Rossing
Diabetes Care|October 17, 1998
Diabetes and risk of adverse events with calcium antagonistsH H Parving, P Rossing
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1973
Simultaneous determination of the transcapillary escape rate of albumin and IgG in normal and long-term juvenile diabetic subjectsH H Parving, N Rossing
Pageof 38

Showing results (31-40 of 376) with videos related to

Sort By:
Pageof 38
Bibliotheca Anatomica|January 1, 1975
Microvascular permeability of albumin in untreated and treated essential hypertension, and during acute induced hypertensionH H Parving
Blood Pressure. Supplement|July 24, 2001
Hypertension and diabetes: the scope of the problemH H Parving
Lancet (London, England)|August 26, 1998
Hypertension Optimal Treatment (HOT) trialH H Parving
Diabetes Care|February 24, 2001
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetesH H Parving, P Rossing
The Journal of Diabetic Complications|April 1, 1988
High blood pressure is a major factor in progression of diabetic nephropathyH H Parving, E Hommel
BMJ (Clinical Research Ed.)|July 22, 1989
Prognosis in diabetic nephropathyH H Parving, E Hommel
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1973
Albumin transcapillary escape rate and plasma volume during long-term beta-adrenergic blockade in essential hypertensionH H Parving, F Gyntelberg
Current Opinion in Nephrology and Hypertension|May 1, 1994
The use of antihypertensive agents in prevention and treatment of diabetic nephropathyH H Parving, P Rossing
Diabetes Care|October 17, 1998
Diabetes and risk of adverse events with calcium antagonistsH H Parving, P Rossing
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1973
Simultaneous determination of the transcapillary escape rate of albumin and IgG in normal and long-term juvenile diabetic subjectsH H Parving, N Rossing
Pageof 38